Published in Medical Imaging Week, February 10th, 2007
This trend article about Pennsylvania State University, U.S., is an immediate alert from NewsRx to identify developing directions of research.
Study 1: Investigators publish new data in the report "Sustained viral response to pegylated interferon alpha-2b and ribavirin in chronic hepatitis C refractory to prior treatment. Hepatitis C virus (HCV) infection refractory to previous therapy is common. Treatment of patients with refractory disease is difficult and less studied," scientists in the United States report.
"Pegylated interferon alpha-2b plus...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Imaging Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.